TenVergert E M, van Enckevort P J, Geertsma A, Koopmanschap M A, van der Bij W, de Boer W J
Academisch Ziekenhuis, Groningen.
Ned Tijdschr Geneeskd. 1998 Apr 25;142(17):957-62.
Assessment of the effectiveness and cost-effectiveness of lung transplantation, and the supply and need of donor lungs in the Netherlands.
Prospective and comparative.
University Hospital Groningen, the Netherlands.
Costs and effects were compared of the situations with and without a lung transplantation programme. Costs and effects were registered during all phases of this programme (November 1990 to February 1996; 76 patients reached the transplantation phase), and the situation without a programme was judged on pre-transplant evidence. The effect of lung transplantation on survival was assessed by means of a Cox regression model, and in the quality of life study of a longitudinal analysis was applied. The supply and the need of donor lungs were based on several registrations.
Lung transplantation led to a significant improvement in survival and quality of life. The average gain in life years and quality adjusted life years (Qalys) were estimated at 4.4 and 5.2, respectively. The average costs per transplanted patient were estimated at Hfl. 670,000 (Hfl. 1 is about 0.5 dollar). The average costs per life year and Qaly gained were estimated at Hfl 153,000 and Hfl. 120,000 (both discounted), respectively. The annual need of donor lungs was estimated at 50-75, the annual supply at 17-27.
Lung transplantation leads to improvement of survival and quality of life. However, it involves considerable costs and the cost-effectiveness is unfavourable compared with other Dutch transplant programmes. Moreover, there is a great discrepancy between the need and supply of donor lungs in the Netherlands.
评估荷兰肺移植的有效性和成本效益,以及供体肺的供需情况。
前瞻性和比较性研究。
荷兰格罗宁根大学医学中心。
比较有无肺移植项目情况下的成本和效果。在该项目的所有阶段(1990年11月至1996年2月;76例患者进入移植阶段)记录成本和效果,无项目情况下的情况根据移植前的证据判断。通过Cox回归模型评估肺移植对生存的影响,并在生活质量研究中采用纵向分析。供体肺的供需基于多项登记。
肺移植显著提高了生存率和生活质量。估计平均生命年增益和质量调整生命年(Qalys)分别为4.4和5.2。每例移植患者的平均成本估计为670,000荷兰盾(1荷兰盾约合0.5美元)。每获得一个生命年和一个Qaly的平均成本估计分别为153,000荷兰盾和120,000荷兰盾(均已贴现)。供体肺的年需求量估计为50 - 75个,年供应量为17 - 27个。
肺移植可提高生存率和生活质量。然而,其成本高昂,与荷兰其他移植项目相比,成本效益不佳。此外,荷兰供体肺的供需之间存在巨大差异。